IN8bio, Inc.

NASDAQ:INAB

0.2254 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -30.437-30.007-28.521-14.653-8.557-5.134-2.081
Depreciation & Amortization 1.8352.5011.1030.7880.0880.0960.096
Deferred Income Tax 00-4.163-0.541000
Stock Based Compensation 54.373.4672.1950.3570.0760.031
Change In Working Capital 0-0.204-0.17-1.8390.6110.093-0.885
Accounts Receivables 000000.03-0.03
Inventory 00000-0.030
Accounts Payables -0.535-0.9811.51-0.319-0.160.141-0.152
Other Working Capital 00.777-1.68-1.520.771-0.048-0.733
Other Non Cash Items -0.54704.1630.5410.3680.0680.07
Operating Cash Flow -24.149-23.34-24.121-13.509-7.133-4.801-2.769
Investing Activities:
Investments In Property Plant And Equipment -0.104-0.6-3.705-0.3090-0.33-0.757
Acquisitions Net 000000.6860
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -0.0830-0.016-0.30900.0010
Investing Cash Flow -0.187-0.6-3.705-0.30900.356-0.757
Financing Activities:
Debt Repayment 0-0.798-0.615-0.7090.17401.264
Common Stock Issued -0.08924.5649.54236.3270.4990.0657.237
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 14.1843.2780.061-2.66323.8440.06514.474
Financing Cash Flow 14.18427.0448.98832.95524.5170.0658.501
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -10.1522.848-18.83819.13717.384-4.384.975
Cash At End Of Period 11.38621.28218.43437.27217.9940.614.99